These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
501 related articles for article (PubMed ID: 19053175)
1. PcG proteins, DNA methylation, and gene repression by chromatin looping. Tiwari VK; McGarvey KM; Licchesi JD; Ohm JE; Herman JG; Schübeler D; Baylin SB PLoS Biol; 2008 Dec; 6(12):2911-27. PubMed ID: 19053175 [TBL] [Abstract][Full Text] [Related]
2. The Polycomb group protein EZH2 directly controls DNA methylation. Viré E; Brenner C; Deplus R; Blanchon L; Fraga M; Didelot C; Morey L; Van Eynde A; Bernard D; Vanderwinden JM; Bollen M; Esteller M; Di Croce L; de Launoit Y; Fuks F Nature; 2006 Feb; 439(7078):871-4. PubMed ID: 16357870 [TBL] [Abstract][Full Text] [Related]
4. Chromatin changes in dicer-deficient mouse embryonic stem cells in response to retinoic acid induced differentiation. Tennakoon JB; Wang H; Coarfa C; Cooney AJ; Gunaratne PH PLoS One; 2013; 8(9):e74556. PubMed ID: 24040281 [TBL] [Abstract][Full Text] [Related]
5. Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylation. Kraft K; Yost KE; Murphy SE; Magg A; Long Y; Corces MR; Granja JM; Wittler L; Mundlos S; Cech TR; Boettiger AN; Chang HY Proc Natl Acad Sci U S A; 2022 May; 119(22):e2201883119. PubMed ID: 35617427 [TBL] [Abstract][Full Text] [Related]
6. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837 [TBL] [Abstract][Full Text] [Related]
7. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells. Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172 [TBL] [Abstract][Full Text] [Related]
8. A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Easwaran H; Johnstone SE; Van Neste L; Ohm J; Mosbruger T; Wang Q; Aryee MJ; Joyce P; Ahuja N; Weisenberger D; Collisson E; Zhu J; Yegnasubramanian S; Matsui W; Baylin SB Genome Res; 2012 May; 22(5):837-49. PubMed ID: 22391556 [TBL] [Abstract][Full Text] [Related]
9. Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells. Angrisano T; Sacchetti S; Natale F; Cerrato A; Pero R; Keller S; Peluso S; Perillo B; Avvedimento VE; Fusco A; Bruni CB; Lembo F; Santoro M; Chiariotti L Nucleic Acids Res; 2011 Mar; 39(6):1993-2006. PubMed ID: 20952403 [TBL] [Abstract][Full Text] [Related]
10. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Balasubramanian S; Adhikary G; Eckert RL Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells. Grimaldi G; Christian M; Steel JH; Henriet P; Poutanen M; Brosens JJ Mol Endocrinol; 2011 Nov; 25(11):1892-903. PubMed ID: 21903722 [TBL] [Abstract][Full Text] [Related]
12. The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing. Nuytten M; Beke L; Van Eynde A; Ceulemans H; Beullens M; Van Hummelen P; Fuks F; Bollen M Oncogene; 2008 Feb; 27(10):1449-60. PubMed ID: 17724462 [TBL] [Abstract][Full Text] [Related]
13. EZH2 and cancer stem cells: fact or fiction? Crea F Epigenomics; 2011 Apr; 3(2):127-8. PubMed ID: 22122274 [No Abstract] [Full Text] [Related]
14. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758 [TBL] [Abstract][Full Text] [Related]
15. EZH2 methyltransferase and H3K27 methylation in breast cancer. Yoo KH; Hennighausen L Int J Biol Sci; 2012; 8(1):59-65. PubMed ID: 22211105 [TBL] [Abstract][Full Text] [Related]
16. SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression. Gjerstorff MF; Relster MM; Greve KB; Moeller JB; Elias D; Lindgreen JN; Schmidt S; Mollenhauer J; Voldborg B; Pedersen CB; Brückmann NH; Møllegaard NE; Ditzel HJ Nucleic Acids Res; 2014 Oct; 42(18):11433-46. PubMed ID: 25249625 [TBL] [Abstract][Full Text] [Related]
18. DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs. So AY; Jung JW; Lee S; Kim HS; Kang KS PLoS One; 2011 May; 6(5):e19503. PubMed ID: 21572997 [TBL] [Abstract][Full Text] [Related]
19. Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells. McGarvey KM; Van Neste L; Cope L; Ohm JE; Herman JG; Van Criekinge W; Schuebel KE; Baylin SB Cancer Res; 2008 Jul; 68(14):5753-9. PubMed ID: 18632628 [TBL] [Abstract][Full Text] [Related]
20. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer. Kodach LL; Jacobs RJ; Heijmans J; van Noesel CJ; Langers AM; Verspaget HW; Hommes DW; Offerhaus GJ; van den Brink GR; Hardwick JC Carcinogenesis; 2010 Sep; 31(9):1567-75. PubMed ID: 20631058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]